Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021983
Company: MMT
Company: MMT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DUODOTE | ATROPINE; PRALIDOXIME CHLORIDE | 2.1MG/0.7ML;600MG/2ML | INJECTABLE;INTRAMUSCULAR | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/28/2006 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | PRIORITY |
Letter (PDF)
Review |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021983s000LTR.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021983_duodote_toc.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
05/17/2022 | SUPPL-38 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021983Orig1s038lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/021983Orig1s038ltr.pdf | |
10/06/2017 | SUPPL-23 | Efficacy-New Patient Population, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021983s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021983Orig1s023ltr.pdf | |
11/03/2016 | SUPPL-22 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/08/2016 | SUPPL-21 | Manufacturing (CMC) |
Label is not available on this site. |
||
04/25/2016 | SUPPL-20 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/11/2015 | SUPPL-19 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/02/2016 | SUPPL-18 | Manufacturing (CMC) |
Label is not available on this site. |
||
09/22/2015 | SUPPL-17 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/21/2014 | SUPPL-14 | Manufacturing (CMC) |
Label is not available on this site. |
||
04/09/2013 | SUPPL-11 | Manufacturing (CMC) |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
05/17/2022 | SUPPL-38 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021983Orig1s038lbl.pdf | |
05/17/2022 | SUPPL-38 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021983Orig1s038lbl.pdf | |
10/06/2017 | SUPPL-23 | Efficacy-New Patient Population | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021983s023lbl.pdf | |
10/06/2017 | SUPPL-23 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021983s023lbl.pdf |